NPPA issued a notification regarding the fixation of the retail price of Cefpodoxime Proxetil IP eq. to Anhydrous Cefpodoxime 50mg + Potassium Clavulanate diluted IP eq. to Clavulanic Acid 31.25mg

Mar 04, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 01, 2024, issued a notification regarding the fixation of the retail price of Cefpodoxime Proxetil IP eq. to Anhydrous Cefpodoxime 50mg + Potassium Clavulanate diluted IP eq. to Clavulanic Acid 31.25mg.

The following has been stated: -

• Each enteric coated tablet contains: Cefpodoxime Proxetil IP eq. to Anhydrous Cefpodoxime 50mg + Potassium Clavulanate diluted IP eq. to Clavulanic Acid 31.25mg for M/s Brooks Laboratories Ltd. (Manufacturer) & M/s German Remedies Pharmaceuticals Pvt Ltd (Marketer) the Retail Price (without local taxes) is 3.017

[Notification No. 19(3848)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT